查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1712506

全球电脑断层扫描市场 - 2025-2033

Global Computed Tomography Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球电脑断层扫描市场规模达到 43.9 亿美元，预计到 2033 年将达到 82.1 亿美元，在 2025-2033 年预测期内的复合年增长率为 7.6%。

电脑断层扫描 (CT)，也称为电脑轴向断层扫描 (CAT)，是一种复杂的成像技术，它利用一束窄 X 光照射患者，并使其围绕身体快速旋转。此过程会产生讯号，经电脑处理后可产生横断面影像，称为「切片」。与传统 X 光相比，这些断层扫描影像为临床医生提供了更详细的资讯。

在检查过程中，CT 机器的电脑会捕捉多个连续的切片。然后可以将这些切片以数位方式组合以形成患者解剖结构的三维（3D）表示。这种 3D 影像有助于更轻鬆地识别基本结构以及潜在的肿瘤或异常，从而提高诊断准确性并有助于治疗计划。

市场动态：

驾驶员和约束装置

CT技术的创新

CT 技术的创新是全球电脑断层扫描市场的关键驱动力。 CT技术的不断创新，例如高切片扫描仪、双能CT以及人工智慧的融合，显着提高了影像品质和诊断准确性。此外，该行业的主要参与者整合了技术创新，从而推动了该市场的成长。

例如，2024 年 6 月，富士软片医疗美洲公司推出了紧凑型 128 层 CT 系统（称为 FCT iStream），在电脑断层扫描 (CT) 市场取得了显着进展。该系统已获得 FDA 510(k) 批准，允许其在临床环境中使用。

此外，2024 年 2 月，飞利浦在 2024 年欧洲放射学大会 (ECR) 上推出了支援人工智慧的 CT 5300 系统，以提高诊断准确性，同时使更广泛的患者能够以更实惠的价格获得先进的影像服务。此创新系统旨在满足临床环境中对高效成像解决方案日益增长的需求。

设备成本高昂

购买和安装先进的电脑断层扫描 (CT) 系统的高成本对许多医疗机构，尤其是小型诊所和医院造成了重大障碍。这项初始投资可能会限制对最新成像技术的使用，尤其是在资源受限的环境中。

了解 CT 扫描仪的成本涉及浏览各种选项，每种选项都旨在满足特定的成像需求并适应不同的预算。 CT 扫描仪有三个不同的价格等级：入门级、中级和高级。每个类别不仅由其价格范围定义，还由所提供的技术水平和诊断能力定义，为医疗机构提供符合其营运要求的选择。

根据 Block Imaging, Inc. 2024 年的资料，入门级 CT 扫描仪是最容易获得的选择，价格从 80,000 美元到 100,000 美元不等。中级 CT 扫描仪的价格在 120,000 美元到 160,000 美元之间，提供了增强的技术和功能。同时，高阶 CT 扫描仪的价格从 20 万美元到 30 万美元不等，采用先进的影像技术，可以满足更复杂的诊断需求。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 技术片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • CT技术的创新
      • 慢性病盛行率上升
    • 限制
      • 设备成本高昂
      • 严格的监管要求
    • 机会
      • 预防性医疗保健需求不断增长
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • 最新进展与突破
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第五章：电脑断层扫描市场（按类型）

  • 固定式CT
  • 便携式CT

第六章：电脑断层扫描市场（依技术）

  • 高切CT
  • 中层CT
  • 低层次CT
  • 锥形束CT（CBCT）

第七章：电脑断层扫描市场（依应用）

  • 肿瘤学
  • 心臟病学
  • 新兴医学
  • 神经血管
  • 肌肉骨骼
  • 其他的

第 8 章：电脑断层扫描市场（依最终使用者划分）

  • 医院
  • 诊断影像中心
  • 其他的

第九章：电脑断层扫描市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第十章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Siemens Healthcare Private Limited
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • GE HealthCare.
  • Canon Medical Systems, USA.
  • Koninklijke Philips NV
  • FUJIFILM India Private Limited
  • Neusoft Medical Systems
  • United Imaging Healthcare Co., Ltd.
  • Koning Health.
  • NeuroLogica Corp.
  • Shenzhen Anke High-tech Co., Ltd.
  • Planmed Oy
  • Stryker

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MA245

The global computed tomography market reached US$ 4.39 billion in 2024 and is expected to reach US$ 8.21 billion by 2033, growing at a CAGR of 7.6 % during the forecast period of 2025-2033.

Computed tomography (CT), also known as computerized axial tomography (CAT), is a sophisticated imaging technique that utilizes a narrow beam of X-rays directed at a patient, which rapidly rotates around the body. This process generates signals that are processed by a computer to create cross-sectional images, referred to as "slices." These tomographic images provide clinicians with more detailed information compared to conventional X-rays.

During the procedure, the CT machine's computer captures multiple successive slices. These slices can then be digitally combined to form a three-dimensional (3D) representation of the patient's anatomy. This 3D imaging facilitates the easier identification of fundamental structures, as well as potential tumors or abnormalities, thereby enhancing diagnostic accuracy and aiding in treatment planning.

Market Dynamics: Drivers & Restraints

Innovations in CT Technology

Innovations in CT technology are crucial drivers for the global computed tomography market. Ongoing innovations in CT technology, such as high-slice scanners, dual-energy CT, and the integration of artificial intelligence, significantly improve imaging quality and diagnostic accuracy. Furthermore, key players in the industry integrate innovations in the technology that would drive this market growth.

For instance, in June 2024, FUJIFILM Healthcare Americas Corporation made notable advancements in the computed tomography (CT) market by launching its compact, 128-slice CT system known as the FCT iStream. This system has received FDA 510(k) clearance, allowing it to be utilized in clinical settings.

Additionally, in February 2024, Philips unveiled the AI-enabled CT 5300 system at the European Congress of Radiology (ECR) 2024 to improve diagnostic accuracy while making advanced imaging more affordable and accessible to a broader range of patients. This innovative system is designed to meet the increasing demand for efficient and effective imaging solutions in clinical environments.

High Costs of Equipment

The high costs associated with purchasing and installing advanced computed tomography (CT) systems create a significant barrier for many healthcare facilities, particularly smaller clinics and hospitals. This initial investment can restrict access to the latest imaging technologies, especially in resource-constrained environments.

Understanding the cost of a CT scanner involves navigating various options, each designed to meet specific imaging needs and accommodate different budgets. There are three distinct price tiers for CT scanners: Entry Level, Intermediate, and Premium. Each category is defined not only by its price range but also by the level of technology and diagnostic capabilities offered, providing healthcare facilities with choices that align with their operational requirements.

According to the Block Imaging, Inc. data in 2024, stated that entry-level CT scanners are the most accessible option, with prices ranging from $80,000 to $100,000. The intermediate tier of CT scanners, priced between $120,000 and $160,000, provides enhanced technology and capabilities. Meanwhile, the premium tier of CT scanners, which range from $200,000 to $300,000, features advanced imaging technologies for more complex diagnostic needs.

Segment Analysis

The global computed tomography market is segmented based on type, technology, application, end-user, and region.

Technology:

The high-slice CT segment in technology is expected to dominate the global computed tomography market with the highest market share

High-slice CT scanners, typically encompassing systems with more than 128 slices (such as 256-, 320-, and 640-slice models), these systems offer faster scan times, increased patient throughput, and lower radiation doses, making them ideal for advanced diagnostic imaging across multiple medical disciplines, including cardiology, neurology, oncology, gastroenterology, and pediatrics.

High-slice CT scanners provide enhanced image clarity, which is crucial for detecting microcalcifications, vascular abnormalities, and early-stage cancers. Innovations such as AI integration, improved dose reduction techniques, and photon-counting CT technology (as seen in Siemens Healthineers' Naeotom Alpha series) are propelling this segment forward. These CT scanners are highly valuable for non-invasive coronary imaging, offering precise assessment of cardiovascular diseases, particularly in patients with irregular heart rates.

For instance, in December 2024, Siemens Healthineers' introduction of the Naeotom Alpha.Pro and Naeotom Alpha. Prime represents a breakthrough in high-slice CT imaging by integrating photon-counting detector (PCD) technology into the field. These additions mark a significant advancement in CT imaging, offering higher resolution, reduced radiation dose, and improved workflow efficiency.

High-slice CT scanners, such as 128-slice, 256-slice, and 320-slice systems, capture large volumes of data with greater speed and resolution. However, conventional high-slice CT scanners still rely on energy-integrating detectors (EIDs), which have limitations in signal processing and image quality. These factors have solidified the segment's position in the global computed tomography market.

Geographical Analysis

North America is expected to hold a significant position in the global computed tomography market with the highest market share

The increasing incidence of chronic illnesses, such as cancer and cardiovascular diseases, is a major driver of CT scanner demand. In particular, oncology applications are seeing significant growth due to higher rates of cancer diagnoses and expanded screening programs, such as low-dose CT scans for lung cancer detection in high-risk groups.

North America, especially the U.S., is witnessing rapid advancements in CT scanner technology, including AI-powered image analysis, photon-counting detectors, and improved resolution with lower radiation doses. Companies like Siemens Healthineers, GE Healthcare, and Canon Medical Systems are investing heavily in research and innovation.

The U.S. government and private institutions are increasing investments in healthcare infrastructure, particularly in advanced diagnostic imaging. The National Institute of Health (NIH) has allocated billions of dollars for cancer and cardiovascular disease research, further boosting the adoption of CT imaging for early disease detection.

Furthermore, key players' product launches and approvals would drive this market growth. For instance, in June 2025, Fujifilm Healthcare Americas Corporation received FDA 510(k) clearance for its new 128-slice computed tomography (CT) system, the FCT iStream. This CT system is designed to provide high-quality imaging while enhancing efficiency and reducing patient radiation exposure. Thus, the above factors are consolidating the region's position as a dominant force in the global computed tomography market.

Competitive Landscape

The major global players in the computed tomography market include Siemens Healthcare Private Limited, GE HealthCare, Canon Medical Systems, USA., Koninklijke Philips N.V., FUJIFILM India Private Limited, Neusoft Medical Systems, United Imaging Healthcare Co., Ltd., Koning Health, NeuroLogica Corp., Shenzhen Anke High-tech Co., Ltd., Planmed Oy, and Stryker among others.

Key Developments

  • In December 2024, CarePlus International Clinics officially inaugurated a cutting-edge Diagnostic Imaging Center that features MRI and CT scan services integrated with advanced Artificial Intelligence (AI) technology. The integration of AI into these imaging technologies is expected to improve the accuracy and efficiency of diagnostic procedures, ultimately benefiting patient care and health outcomes.
  • In July 2024, Trivitron Healthcare reached a significant milestone by becoming the first Indian company to secure regulatory approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB), and the Central Drugs Standard Control Organization (CDSCO) for the manufacturing of CT scanners.
  • In February 2024, Koning Health announced that it had received regulatory clearance from the Federal Authority for Nuclear Regulation (FANR) in the United Arab Emirates (UAE). This approval enables Koning to introduce its innovative breast computed tomography (CT) technology, specifically the Vera Complete system, into the UAE market.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global computed tomography market report delivers a detailed analysis with 76 key tables, more than 67 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Innovations in CT Technology
      • 3.1.1.2. Rising Prevalence of Chronic Diseases
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Equipment
      • 3.1.2.2. Strict Regulatory Requirements
    • 3.1.3. Opportunity
      • 3.1.3.1. Increasing Demand for Preventive Healthcare
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Latest Developments and Breakthroughs
  • 4.3. Regulatory and Reimbursement Landscape
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. Asia Pacific
    • 4.3.4. South America
    • 4.3.5. Middle East & Africa
  • 4.4. Porter's Five Forces Analysis
  • 4.5. Supply Chain Analysis
  • 4.6. Patent Analysis
  • 4.7. SWOT Analysis
  • 4.8. Unmet Needs and Gaps
  • 4.9. Recommended Strategies for Market Entry and Expansion
  • 4.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.11. Pricing Analysis and Price Dynamics

5. Computed Tomography Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Stationary CT *
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Portable CT

6. Computed Tomography Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. High-Slice CT*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Mid-Slice CT
  • 6.4. Low-Slice CT
  • 6.5. Cone Beam CT (CBCT)

7. Computed Tomography Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Oncology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Emerging Medicine
  • 7.5. Neurovascular
  • 7.6. Musculoskeletal
  • 7.7. Others

8. Computed Tomography Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Others

9. Computed Tomography Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Siemens Healthcare Private Limited*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. GE HealthCare.
  • 11.3. Canon Medical Systems, USA.
  • 11.4. Koninklijke Philips N.V.
  • 11.5. FUJIFILM India Private Limited
  • 11.6. Neusoft Medical Systems
  • 11.7. United Imaging Healthcare Co., Ltd.
  • 11.8. Koning Health.
  • 11.9. NeuroLogica Corp.
  • 11.10. Shenzhen Anke High-tech Co., Ltd.
  • 11.11. Planmed Oy
  • 11.12. Stryker

LIST NOT EXHAUSTIVE

12. Assumptions and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us